pentoxifylline has been researched along with B-Cell Chronic Lymphocytic Leukemia in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "), treated for ten years only by theophylline for bronchial asthma, we observed spontaneous apoptosis of B lymphocytes (10%)." | 3.69 | [In vitro induction of apoptosis in chronic lymphoid leukemia B lymphocytes by theophylline: therapeutic applications]. ( Baudet, S; Binet, JL; Mentz, F; Merle-Béral, H; Ouaaz, F, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Napolitano, R | 1 |
| De Matteis, S | 1 |
| Lucchesi, A | 1 |
| Carloni, S | 1 |
| Cangini, D | 1 |
| Musuraca, G | 1 |
| Liardo, EV | 1 |
| Norata, M | 1 |
| Fattori, PP | 1 |
| Cattaneo, F | 1 |
| Patrussi, L | 1 |
| Capitani, N | 1 |
| Frezzato, F | 1 |
| D'Elios, MM | 1 |
| Trentin, L | 1 |
| Semenzato, G | 1 |
| Baldari, CT | 1 |
| Binet, JL | 2 |
| Mentz, F | 2 |
| Baudet, S | 1 |
| Ouaaz, F | 1 |
| Merle-Béral, H | 2 |
| Leblond, V | 1 |
4 other studies available for pentoxifylline and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Pentoxifylline-Induced Apoptosis in Chronic Lymphocytic Leukemia: New Insights into Molecular Mechanism.
Topics: Antineoplastic Agents; Apoptosis; Cells, Cultured; Dose-Response Relationship, Drug; Drug Screening | 2018 |
Expression of the p66Shc protein adaptor is regulated by the activator of transcription STAT4 in normal and chronic lymphocytic leukemia B cells.
Topics: Apoptosis; B-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Chromatin Immunoprecipitation; Gene | 2016 |
[In vitro induction of apoptosis in chronic lymphoid leukemia B lymphocytes by theophylline: therapeutic applications].
Topics: Aged; Antineoplastic Agents, Alkylating; Apoptosis; Asthma; B-Lymphocytes; Bronchodilator Agents; Ch | 1995 |
Synergistic action of alkylating agents and methylxanthine derivatives in the treatment of chronic lymphocytic leukemia.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyc | 1995 |